Stocktoria
NovaBridge Biosciences NBP
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-01-17
Chart by TradingView
1/9
Piotroski F — financial health
-6.11
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | — | — | $632,000 | -$1.6M | $88.0M |
| Operating income | -$94.3M | -$51.4M | -$72.0M | -$53.1M | — |
| Net income | -$46.3M | -$22.2M | -$207.7M | -$371.1M | -$365.9M |
| Operating cash flow | -$20.6M | -$52.7M | -$72.7M | -$49.6M | -$152.7M |
| Free cash flow | -$20.6M | -$52.7M | -$72.9M | -$51.7M | -$157.4M |
| Total assets | $260.5M | $212.7M | $368.9M | $590.6M | $878.9M |
| Total liabilities | $29.6M | $11.5M | $126.3M | $168.7M | $163.5M |
| Shareholders' equity | $230.9M | $201.2M | $242.6M | $417.8M | $715.1M |
| Ratios | |||||
| Operating margin | — | — | -11395.1% | 3422.2% | — |
| Net margin | — | — | -32868.5% | 23923.5% | -415.6% |
| FCF margin | — | — | -11528.6% | 3331.6% | -178.8% |
| Return on assets | -17.8% | -10.5% | -56.3% | -62.8% | -41.6% |
| Return on equity | -20.0% | -11.1% | -85.6% | -88.8% | -51.2% |
| Current ratio | 8.09 | 20.90 | 5.67 | 4.78 | 7.66 |
| Revenue growth | — | — | -140.7% | -101.8% | -94.3% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 1,389,403 | $3.4M |
| RENAISSANCE TECHNOLOGIES LLC | 272,412 | $670,134 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -6.11 (distress)
- Working capital / assets 0.732
- Retained earnings / assets -5.114
- EBIT / assets -0.362
- Equity / liabilities 7.807
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001778016 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.